Tech Company Financing Transactions
PATH EX Funding Round
IAG Capital Partners, Fitz Gate Ventures and TMC Venture Fund participated in a $5 million venture round for PATH EX. The funding round was announced by the company on 5/9/2025.
Transaction Overview
Company Name
Announced On
5/9/2025
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the development and future commercialization of CycloPE®.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
111 10th Avenue South 105
Nashville, TN 37203
USA
Nashville, TN 37203
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
PATH EX is developing an extracorporeal blood cleansing device designed to selectively remove pathogens, including multi-drug resistant bacteria, and endotoxins from circulating blood. This device is investigational and is limited by federal law to investigational use. The PATH EX device significantly reduces pathogen and endotoxin levels. The device represents a novel, promising strategy for immediate treatment in bacteremia and sepsis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sinead Miller
Browse more venture capital transactions:
Prev: 5/9/2025: Quantix venture capital transaction
Next: 5/9/2025: Vestigas venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs